Sarah Teichmann: Science always wins if we work together.

IF 10.6 1区医学 Q1 IMMUNOLOGY

Journal of Experimental Medicine Pub Date : 2025-10-06 Epub Date: 2025-09-03 DOI:10.1084/jem.20251649

Lucie Van Emmenis

引用次数: 0

Abstract

Sarah Teichmann is a professor at the University of Cambridge, where she leads a research group that uses a combination of genomics, artificial intelligence (AI), and bioinformatics to further understand various aspects of immunity. She is also one of the co-founders of the Human Cell Atlas, a nonexecutive director of 10x Genomics, an advisor for multiple biotech startups, and now a part-time Vice President, Translational Research at GlaxoSmithKline (GSK). We spoke to Sarah about expanding beyond academic science in your career, dealing with uncertainty in the workplace, and being able to carve out time for yourself despite having multiple demands on your time.

查看原文本刊更多论文

Sarah Teichmann：如果我们共同努力，科学总会取得胜利。

Sarah Teichmann是剑桥大学的一名教授，她领导的一个研究小组将基因组学、人工智能（AI）和生物信息学结合起来，进一步了解免疫的各个方面。她也是the Human Cell Atlas的联合创始人之一，10x Genomics的非执行董事，多家生物技术初创公司的顾问，现在是葛兰素史克公司（GSK）的兼职副总裁，负责转化研究。我们和Sarah讨论了在职业生涯中超越学术科学，处理工作场所的不确定性，以及在有多种需求的情况下能够为自己腾出时间。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Experimental Medicine 医学-免疫学

CiteScore

26.60

自引率

1.30%

发文量

189

审稿时长

3-8 weeks

期刊介绍： Since its establishment in 1896, the Journal of Experimental Medicine (JEM) has steadfastly pursued the publication of enduring and exceptional studies in medical biology. In an era where numerous publishing groups are introducing specialized journals, we recognize the importance of offering a distinguished platform for studies that seamlessly integrate various disciplines within the pathogenesis field. Our unique editorial system, driven by a commitment to exceptional author service, involves two collaborative groups of editors: professional editors with robust scientific backgrounds and full-time practicing scientists. Each paper undergoes evaluation by at least one editor from both groups before external review. Weekly editorial meetings facilitate comprehensive discussions on papers, incorporating external referee comments, and ensure swift decisions without unnecessary demands for extensive revisions. Encompassing human studies and diverse in vivo experimental models of human disease, our focus within medical biology spans genetics, inflammation, immunity, infectious disease, cancer, vascular biology, metabolic disorders, neuroscience, and stem cell biology. We eagerly welcome reports ranging from atomic-level analyses to clinical interventions that unveil new mechanistic insights.